Past Gallery
(408) 352-1010


International Pharma Research & Drug Delivery Summit ( IPRDS 2019) will take place in the gorgeous city of Brussels, Belgium in June10-12, 2019 and the theme of the conference is “A Global Review and Forecast on Pharma R&D”. Pharma Research & Drug delivery Summit is the leading platform bringing together all professionals, industry experts, and academia in Pharmaceutics & formulations, Drug Development and Delivery. 

Mark your calendars now and for more details please contact us at



Meet renowned speakers, world's leading CEO's, Directors, Pharma researchers, Pharmacists. To know about the ongoing research projects in the field of Pharma. To keep abreast of all advances in Pharma R&D. Chance to collaborate research organizations with industries. To share the research ideas and implement them in Pharma research. Best opportunity to reach the largest assemblage of participants from Pharma Societies.



Our conferences are about you, our clients, so we work for unqualified success and we do that quietly, professionally and impeccably. We've built a reputation for creating and delivering inspirational conferences and executing them flawlessly first time round. We work really hard to achieve this and our success is down to the dynamics of a team who are down-to-earth.



INNOVINC conferences cover a broad range of research in the area of life science and technology. Attending a Innovinc Conference will provide immense access to ground-breaking research presentations and discussions which provides the best break to develop collaborations, get innovative ideas and opportunity for your own work.

About Conference

Pharma Research & Drug delivery Summit (IPRDS 2019) is the leading platform bringing together all professionals, industry experts and academia in Pharmaceutics & formulations, Drug development and Delivery. IPRDS 2019 creates a unique platform to discuss the challenges and showcase the latest technologies in formulation and drug delivery to improve solubility, stability and bioavailability of Drug, enhance the drug design and fasten the Drug development process.

This is your opportunity to learn from formulation, development and Drug Delivery thought leaders and experts in Industry and academia focussing on Small Molecules, Biologics, and Technology & Innovation and discuss their impact on product enhancement and patient experience.

The conference will be packed with presentations, talks, real time case studies, workshops, and panel and roundtable discussions with plenty of networking opportunity. There will be poster presentation and Award Function to recognise innovation in Drug Formulation and Delivery technologies.

  • slider-home
  • slider-home

Scientific Sessions

Conference sessions may be geared toward participants with different levels of experience or different positions. Main conference sessions include the following 17 tracks.Choose to follow one track or move between tracks to create your own personalized conference experience.

Organizing Committee

Keynote Talks/Plenary Talks

Why to Attend

Innovinc International welcomes you to attend the International Pharma Research & Drug Delivery Summit during June 10 - 12, 2019 at Brussels, Belgium. To meet renowned speakers, world's leading CEO's, Directors, decision and policy makers.

To Meet renowned speakers, world's leading CEO's, Directors, Pharma researchers, Pharmacists. To know about the ongoing research projects in the field of Pharma. To keep abreast of all advances in Pharma R&D. Chance to collaborate research organizations with industries. To share the research ideas and implement them in Pharma research. Best opportunity to reach the largest assemblage of participants from Pharma Societies.



day 1 agenda

Mon , Jun 10, 2019

  • 08:00
  • Registrations

  • 08:45
  • Opening Ceremony & Welcome Speech

  • 09:00
  • Keynote Talk-1 : 3D Printed Corneal Equivalent

    Sachdeva Mandip S, Professor of Pharmaceutics, Florida A&M University, USA

  • 09:30
  • Keynote Talk-2 : Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.

    Kaliappanadar Nellaiappan, Director of Product Development at Curirx inc, USA


  • 10:00
  • Keynote Talk 3 : Preparation and nanoformulation of new quinolone scaffold-based anticancer agents: Enhancing solubility for better cellular delivery

    Reem K. Arafa, Professor of Biomedical Sciences, Zewail City of Science and Technology, Egypt

  • 10:30
  • Keynote Talk-4: Lung Delivery of Biopharmaceuticals using Nanocarrier Systems

    Imran Saleem, Reader in Nanomedicine, Liverpool John Moores University, UK

  • 11:00
  • Refreshments

  • 11:20
  • High gene delivery efficiency mediated by lipid- and polymer-based nanosystems

    Henrique Faneca, Center for Neuroscience and Cell Biology, University of Coimbra,Portugal

  • 11:40
  • Scientific Session : Targeting c-MYC and c-MYC regulating microRNAs in ovarian cancer with liposomal-interference RNA

    Pablo Vivas-Mejia, Assistant professor in the Cancer Center and the Department of Biochemistry of the University of Puerto Rico Medical Sciences, Puerto Rico

  • 12:00
  • Scientific Session : Cell-based chemoresistance models to evaluate combinational nanoformuations

    Badiree Konkimalla, Reader-F, National Institute of Science Education and Research (NISER), India

  • 12:20
  • Scientific Session: Inorganic Nanomaterials as Carriers in Targeted Delivery of Anticancer Drugs

    R.M.G. Rajapakse, University of Peradeniya, Sri Lanka 

  • 12:40
  • Nanoparticle Engineering towards Highly Efficient Drug Delivery Systems and SERS-based Bio-Sensing

    Beatrice Fortuni, KU Leuven, Belgium

  • 13:00
  • Lunch at Restaurant

  • 13:45
  • Group photo

  • 13:50
  • Scientific Session : The Importance of Modernization of Acetaminophen (Paracetamol) containing Documentary Standards to Global Public Health

    Clydewyn Anthony, United States Pharmacopeial Convention, USA

  • 14:10
  • Scientific Session : Marine Compound Xyloketal B as a Novel Drug Candidate for Cardiovascular and neuronal protection

    Guan-Lei Wang, Professor of Pharmacology, Sun Yat-sen University, China

  • 14:30
  • Scientific session : Amino acid based surfactants: a class of amphiphiles with potential applications in the pharmaceutical field

    Diego Romano Perinelli, School of Pharmacy, University of Camerino, Italy

  • 14:50
  • Scientific Session : Development and Pharmacokinetic Evaluations of a Co-Solvent and a PLGA-based Nanospheres of Itraconazole for Intravenous Administrations

    Dong Liang, Texas Southern University, USA

  • 15:10
  • Scientific session : Subcutaneous formulation of furosemide: endless opportunities for an old drug.

    Tamas Alexy, Assistant Professor, Medicine/Cardiology, University of Minnesota, USA

  • 15:30
  • Scientific Session : Treatment of animal model for hot flushes by nasal administration of a non-hormonal drug delivery system

    Hiba Natsheh, Post-doctoral fellow at The Hebrew University, Israel

  • 15:50
  • Coffee Break

  • 16:10
  • Special Session: Phytochemical compounds of Selected Lebanese Plants with Potential Biological activities

    Maha Aboul-Ela, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Lebanon​

  • 16:30
  • Special Session: Contribution of Developed Prototype Research Software Relevant to Infants’ Prakriti (Physical constitution) Assessment for Vikriti (Pathological condition) Management and Possible Future Disorders

    Srivastava Niraj , Government Ayurvedic PG College, India

  • 16:50
  • Special Session : Role of Leech Therapy in Different Diseases W.S.R. Deep vein Thrombosis (DVT)

    Varsha Saxena, Uttarakhand  Ayurveda University (UAU), India

  • 17:10
  • Panel Discussion

  • Note:
  • This is the tentative program and Program schedule is subjected to change with final allotment of speaker slots

day 2 agenda

Tue , Jun 11, 2019

  • 08:30
  • Registrations

  • 09:00
  • Keynote Talk-1: Bridging Discovery program to Development-The Making of a Phase I Trial Study

    Elizabeth Kwong,  Director & CEO of Kwong Eureka Solutions, Canada

  • 10:10
  • Keynote Talk-3 : Material properties impacting micronization behavior of a crystalline drug

    Ajit Narang, Sr. Scientist, Genentech, Inc., USA

  • 10:10
  • Keynote Talk 4: Development of a novel anti-Ran-GTPase peptide nanoparticles as a novel approach for anti-metastatic therapies

    Ahmed Faheem, University of Sunderland, UK

  • 10:40
  • Keynote Talk 4: Development of integrated enzymatic electrophoretic methodologies for the quality control of therapeutic biomolecules

    Catherine Perrin, Professor in analytical chemistry at the faculty of pharmacy of Montpellier (University of Montpellier), France

  • 11:10
  • Refreshments

  • 11:30
  • Scientific Session : Biorelevant Dissolution to Facilitate Formulation Development of a BSC Class 2 Basic Compound and Overcome Drug-Drug Interaction with Acid Reducing Agents

    Dawen Kou, Senior Scientist in Genentech at South San Francisco, CA, USA

  • 11:50
  • Scientific Sessions : Our smeared FE computational models for drug delivery in organs and tumors

    Milos Kojic, Houston Methodist, BioIRC Research Center, Serbian Academy of Sciences and Arts, Serbia

  • 12:10
  • Scientific Session : Divorce uses of gabapentenoids and it’s implications- a new public health issue

    Shubhakaran Khichar, Professor of Neurology at Government Medical College, India

  • 12:30
  • Scientific Session: Chiral HPLC Resolution of a Potentially Serious Global Health Crisis

    Clydewyn Anthony, United States Pharmacopeial Convention, USA


  • 12:50
  • Scientific Session: Patient Registries and the EU Regulatory Framework: Some Reflections

    Charlotte Ryckman, Covington & Burling LLP

  • 13:20
  • Lunch at Restaurant

  • 14:10
  • Scientific Session : Precision Medicine Collaborations at the Industry-Academic Interface

    Patrick J Silva, University of Arizona Health Sciences, USA

  • 14:30
  • Scientific session : A Pharmacokinetic Study of Medazolam and Ketamine in Patients on Extracorporeal Membrane Oxygenation Therapy

    Gagan Kaushal, Associate Professor in Pharmaceutics, Thomas Jefferson University, USA

  • 14:50
  • Scientific Session: Analysis 3-Hydroxypropyl Mercapturic Acid (3-HPMA) in Urine of Breast Cancer Patient for Monitoring the Toxicity of Cyclophosphamide

    Yahdiana Harahap, Faculty of Pharmacy, Universitas Indonesia, Indonesia

  • 15:10
  • Scientific Session: Bactericidal autophagy inhibitors in cancer treatment

    Benedetto Grimaldi , Italian Institute of Technology (IIT), Italy

  • 15:30
  • Scientific Session : In vitro lung epithelial cell transport and anti-interleukin-8 releasing activity of liposomal ciprofloxacin

    Ruba S. Darweesh, Assistant Professor of Pharmaceutical Sciences, Jordan University of Science and Technology, Jordan

  • 15:50
  • Scientific Session : 3D Bioprinting Substitute Encapsulated with Cells and Growth Factor

    Lei Nie, KU Leuven, Belgium

  • 16:10
  • Scientific Session : Spiro-fused cyclopropa[a]pyrrolizines and 3-azabicyclo[3.1.0]hexanes as potential antitumor agents

    Vitali M Boitsov, Saint-Petersburg Academic University, St Petersburg, Russian Federation, 

  • 16:30
  • Coffee Break

  • 16:50
  • Panel Discussion

  • Note:
  • This is the tentative program and Program schedule is subjected to change with final allotment of speaker slots

day 3 agenda

Wed , Jun 12, 2019

  • 10:00
  • Networkig

  • 12:30
  • Lunch at Restaurant

Conference Agenda Download


Don t Miss This Amazing Conference And Opportunities

Past Conference Gallery

Promote Partners